The Blog dot

Currently browsing: Genetics

Back to overview

CRISPR: editing the drug discovery workflow

By Caroline Huber

Gene editing is crucial to pharmaceutical development, and the latest and hottest development, CRISPR-Cas9 promises to revolutionize the role gene editing plays in drug discovery and even therapeutics.

Read more

Epigenetics: Adding a new layer to health - Part II

By Kevin Moore
(Part 2 of 2). The effect of one's lifestyle on the epigenetic steerage of future generations, reviewed in Part I of this series, is a sobering thought. But these insights in epigenetic-based gene regulation are also opening up new possibilities in the development of novel drugs to combat, for example, cardiovascular disease, metabolic disorders, neurological disease and cancer.

Read more

Epigenetics: Adding a new layer to health - Part I

By Kevin Moore
(Part 1 of 2). We are constantly bombarded with advice on what to eat and drink, and how to exercise. Pregnant women are particularly in the spotlight, being told to avoid exposing their developing fetus to alcohol, tobacco, chemical pollutants, and stress. Who can avoid the repeated warnings about how the environment affects our health, including provoking asthma, heart disease, and metabolic disorders? In this dizzying maze of risk and uncertainty, scientific research and the pharmaceutical industry are striving to find new ways to combat disease.
Read more

Country selection

appears to be your location. To view country specific information on the Tecan web site, please accept or change country below.

accept country change country select country

Tecan Cookie Policy

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Disclaimer